高级检索
当前位置: 首页 > 详情页

Multicentre, randomized comparison of two-stent and provisional stenting techniques in patients with complex coronary bifurcation lesions: the DEFINITION II trial

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China [2]Division of Cardiology, General Hospital of NorthernTheater Command, Shenyang, China [3]Division of Cardiology, Xijing Hospital, 4th Military Medical University, Xi’an, China [4]Division of Cardiology, Medistra Hospital, Universityof Indonesia Medical School, Jakarta, Indonesia [5]Division of Cardiology, Binawaluya Cardiac Center, Jakarta, Indonesia [6]Division of Cardiology, Medicine Siriraj Hospital, Bangkok,Thailand [7]Division of Cardiology, Guangzhou Red Cross Hospital, Guangzhou, China [8]Division of Cardiology, Pederzoli Hospital-Peschiera del Garda, Verona, Italy [9]Division ofCardiology, Oriental General Hospital, Huainan, China [1010]Division of Cardiology, Nanjing Heart Center, Nanjing, China [11]Division of Cardiology, Otamendi Hospital, BuenosAires, Argentina [12]Division of Cardiology, Bangkok General Hospital, Bangkok, Thailand [13]Division of Cardiology, Jilin Cardiovascular Hospital, Changchun, China [14]Division ofCardiology, Taicang 1st People’s Hospital, Taicang, China [15]Division of Cardiology, Bangplee Hospital, Bangkok, Thailand [16]Division of Cardiology, Wuhan Tongji Hospital,United Medical University, Wuhan, China [17]Division of Cardiology, Fujian Medical University Union Hospital, Fujian Institute of Coronary Artery Disease, Fujian Heart MedicalCenter, Fuzhou, China [18]Division of Cardiology, Shanghai Ruijin Hospital, Shanghai Communication University, Shanghai, China [19]Division of Cardiology, Xinhua Hospital,Huainan, China [20]Division of Cardiology, Gansu Provincial People’s Hospital, Lanzhou, China [21]Division of Cardiology, Beijing Anzhen Hospital, Capital Medical University,Beijing, China [22]Division of Cardiology, Jiangxi Provincial People’s Hospital, Nanchang, China [23]Division of Cardiology, Anhui Provincial Hospital, Hefei, China [24]Division ofCardiology, Tianjin 4th Central Hospital, Tianjin, China [25]Division of Cardiology, Wuxi 3rd People’s Hospital, Wuxi, China [26]Division of Cardiology, Yixing People’s Hospital,Yixing, China [27]Division of Cardiology, Cheng-Hsin General Hospital, Taipei, China [28]Division of Cardiology, Cangzhou Central Hospital, Cangzhou, China [29]Division ofCardiology, Xiamen Cardiovascular Hospital, Xiamen University, Xiamen, China [30]Division of Cardiology, Jintan Traditional Chinese Medicine Hospital, Jintan, China [31]Divisionof Cardiology, Liyang Hospital of Traditional Chinese Medicine, Liyang, China [32]Division of Cardiology, Chuzhou People’s Hospital, Chuzhou, China [33]Division of Cardiology,Huaian 2nd People’s Hospital, Huaian, China [34]Division of Cardiology, Xinyang Central Hospital, Xinyang, China [35]Division of Cardiology, Lianyungang Traditional ChineseMedicine Hospital, Lianyungang, China [36]Division of Cardiology, XuanCheng Central Hospital, Xuancheng, China [37]Division of Cardiology, Xuyi People’s Hospital, Xuyi, China [38]Division of Cardiology, Jintan People’s Hospital, Jintan, China [39]Division of Cardiology, Huainan People’s Hospital, Huainan, China [40]Division of Cardiology, 2nd People’sHospital, Shandong University, Jinan, China [41]Division of Cardiology, Changzhou Traditional Chinese Medicine Hospital, China [42]Division of Cardiology, Affiliated Hospital ofGuangdong Medical University, Zhanjiang, China [43]Division of Cardiology, Anqing 1st People’s Hospital, Anqing, China [44]Division of Cardiology, Changshu People’s Hospital,Changshu, China [45]Division of Cardiology, 17th Metallurgical Hospital, Maanshan, China [46]Division of Cardiology, Qingdao Campus of Fuwai Hospital, Qingdao, China [47]Division of Cardiology, Xuzhou 2nd People’s Hospital, Xuzhou, China [48]Division of Cardiology, Wuxi Huishan District People’s Hospital, Wuxi, China [49]Division ofCardiology, Nanjing 81 Hospital, Nanjing, China [50]Division of Cardiology, Hongze People’s Hospital, Huai’an, China [51]Trinity College, University of Toronto, Toronto, Canada [52]Mailman School of Public Health, Columbia University, New York, NY, USA [53]The Zena and Michael A. Wiener Cardiovascular Institute, Ican School of Medicine at MountSinai, New York, NY, USA and The Cardiovascular Research Foundation, New York, NY, USA [54]College of Pharmacy, Nanjing Medical University, Nanjing, China
出处:
ISSN:

关键词: Coronary bifurcation lesions Provisional stenting Stent thrombosis Target lesion failure Two-stent strategy

摘要:
AIM: The present study aimed to assess the benefits of two-stent techniques for patients with DEFINITION criteria-defined complex coronary bifurcation lesions. METHODS AND RESULTS: In total, 653 patients with complex bifurcation lesions at 49 international centres were randomly assigned to undergo the systematic two-stent technique (two-stent group) or provisional stenting (provisional group). The primary endpoint was the composite of target lesion failure (TLF) at the 1-year follow-up, including cardiac death, target vessel myocardial infarction (TVMI), and clinically driven target lesion revascularization (TLR). The safety endpoint was definite or probable stent thrombosis. At the 1-year follow-up, TLF occurred in 37 (11.4%) and 20 (6.1%) patients in the provisional and two-stent groups, respectively [77.8%: double-kissing crush; hazard ratio (HR) 0.52, 95% confidence interval (CI) 0.30-0.90; P = 0.019], largely driven by increased TVMI (7.1%, HR 0.43, 95% CI 0.20-0.90; P = 0.025) and clinically driven TLR (5.5%, HR 0.43, 95% CI 0.19-1.00; P = 0.049) in the provisional group. At the 1 year after indexed procedures, the incidence of cardiac death was 2.5% in the provisional group, non-significant to 2.1% in the two-stent group (HR 0.86, 95% CI 0.31-2.37; P = 0.772). CONCLUSION: For DEFINITION criteria-defined complex coronary bifurcation lesions, the systematic two-stent approach was associated with a significant improvement in clinical outcomes compared with the provisional stenting approach. Further study is urgently warranted to identify the mechanisms contributing to the increased rate of TVMI after provisional stenting. STUDY REGISTRATION: http://www.clinicaltrials.com; Identifier: NCT02284750. Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: [email protected]

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
JCR分区:
出版当年[2018]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China
共同第一作者:
通讯作者:
通讯机构: [1]Division of Cardiology, Nanjing First Hospital, Nanjing Medical University, 68 Changle Road, Nanjing 210006, China [54]College of Pharmacy, Nanjing Medical University, Nanjing, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2022 今日访问量:0 总访问量:648 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号